PUBLISHER: The Business Research Company | PRODUCT CODE: 1619571
PUBLISHER: The Business Research Company | PRODUCT CODE: 1619571
Estrogen Blockers Global Market Report 2024
Estrogen blockers are substances that inhibit the effects of estrogen in the body by either binding to estrogen receptors or reducing estrogen production. They are primarily used to treat estrogen receptor-positive breast cancer by preventing estrogen from promoting cancer cell growth. Additionally, estrogen blockers help manage conditions such as gynecomastia in men, endometriosis, and certain types of infertility by adjusting hormone levels.
The main types of estrogen blockers include selective estrogen receptor modulators (SERMs), aromatase inhibitors, estrogen receptor downregulators (ERDs), and other related substances. SERMs are a class of drugs that interact with estrogen receptors, acting as estrogen agonists in some tissues and antagonists in others. These products are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and are used for various applications such as treating breast cancer, hormone replacement therapy (HRT), infertility treatment, post-menopausal osteoporosis, and other conditions.
The estrogen blockers market research report is one of a series of new reports from The Business Research Company that provides estrogen blockers market statistics, including estrogen blockers industry global market size, regional shares, competitors with an estrogen blockers market share, detailed estrogen blockers market segments, market trends and opportunities, and any further data you may need to thrive in the estrogen blockers industry. This estrogen blockers market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The estrogen blockers market size has grown strongly in recent years. It will grow from $8.72 billion in 2023 to $9.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth observed during the historic period can be attributed to a rise in prostate cancer prevalence, an increase in hormone-related disorders, and greater adoption of hormone replacement therapy (HRT).
The estrogen blockers market size is expected to see strong growth in the next few years. It will grow to $12.37 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth during the forecast period can be attributed to the increasing prevalence of breast cancer, growing awareness and screening initiatives, a rise in estrogen-related conditions worldwide, and the expanding use of estrogen blockers beyond cancer treatment. Key trends expected to drive this growth include advancements in the development of estrogen blockers, the discovery of novel blockers with enhanced efficacy, strategic partnerships among market players, and new product approvals.
The increasing incidence of breast cancer is projected to drive the growth of the estrogen blocker market. Breast cancer originates in the breast tissue, primarily affecting the milk ducts and lobules, and arises from mutations in normal breast cells that lead to uncontrolled growth and tumor formation. The rise in breast cancer cases can be attributed to factors such as an aging population, lifestyle changes such as higher alcohol consumption and sedentary behavior, and improved detection through advanced screening and diagnostic methods. Estrogen blockers are used in breast cancer treatment by inhibiting the hormone estrogen, which can fuel the growth of certain breast cancer cells. These blockers are effective in slowing or halting the growth of hormone receptor-positive breast cancers, aiding in treatment and potentially reducing the risk of recurrence. For instance, in January 2024, the Australian Institute of Health and Welfare reported that 20,458 cases of breast cancer were diagnosed in females in 2023, reflecting an age-standardized incidence rate of 128.6 cases per 100,000 females. This is a slight increase from the 20,004 cases diagnosed in 2022, with an age-standardized incidence rate of 128.2 cases per 100,000 females. This rising prevalence is expected to fuel growth in the estrogen blocker market.
Companies in the estrogen blocker market are concentrating on developing advanced drugs that combine AKT (Protein Kinase B) inhibitors with selective estrogen receptor degraders (SERDs) to improve treatment efficacy and address resistance in breast cancer therapy. This combination therapy targets survival pathways in cancer cells and degrades estrogen receptors, aiming to inhibit tumor growth and overcome resistance to hormonal treatments. For example, in November 2023, AstraZeneca, a UK-based pharmaceutical company, received FDA approval for Truqap (capivasertib), an AKT inhibitor, used in conjunction with Faslodex (fulvestrant), a SERD. This approval is for treating adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer with specific biomarker alterations, such as PIK3CA, AKT1, or PTEN. This is particularly notable for patients who have progressed on at least one endocrine-based therapy or experienced recurrence within 12 months after completing adjuvant therapy.
In July 2024, Exscientia, a UK-based biotechnology company, acquired GT Apeiron's stake in its oral CDK7 inhibitor program for an undisclosed amount. This acquisition enhances Exscientia's oncology portfolio and positions the company to expand into combination therapies for HR+/HER2- breast cancer by late 2024. This development aligns with Exscientia's commitment to AI-driven drug design aimed at developing highly effective cancer treatments. GT Apeiron is a US-based expert in applied artificial intelligence and drug discovery, providing valuable expertise to support Exscientia's initiatives
Major companies operating in the estrogen blockers market are Pfizer Inc, F. Hoffmann-La Roche AG, Merck & Co. Inc, Novartis AG, Sanofi S.A, AstraZeneca PLC, GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc, Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Ipsen S.A., Cadila Pharmaceuticals Ltd., Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Lupin Limited, Glenmark Pharmaceuticals Limited, Alvogen Inc., Alembic Pharmaceuticals Limited, Olema Pharmaceuticals Inc, Cipla Inc, Criterium Inc
North America was the largest region in the estrogen blockers market in 2023. The regions covered in the estrogen blockers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the estrogen blockers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The estrogen blockers market consists of sales of tamoxifen, raloxifene, toremifene, anastrozole, letrozole, exemestane, and fulvestrant. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Estrogen Blockers Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on estrogen blockers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for estrogen blockers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The estrogen blockers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Selective Estrogen Receptor Modulators (SERMs); Aromatase Inhibitors; Estrogen Receptor Downregulators (ERDs); Other Products
- 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- 3) By Application: Breast Cancer Treatment; Hormone Replacement Therapy (HRT); Infertility Treatment; Post-Menopausal Osteoporosis; Other Applications
- Companies Mentioned: Pfizer Inc; F. Hoffmann-La Roche AG; Merck & Co. Inc; Novartis AG; Sanofi S.A
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Estrogen Blockers Market Characteristics
3. Estrogen Blockers Market Trends And Strategies
4. Estrogen Blockers Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Estrogen Blockers Market Size and Growth
- 5.1. Global Estrogen Blockers Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Estrogen Blockers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Estrogen Blockers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Estrogen Blockers Market Segmentation
- 6.1. Global Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Selective Estrogen Receptor Modulators (SERMs)
- Aromatase Inhibitors
- Estrogen Receptor Downregulators (ERDs)
- Other Products
- 6.2. Global Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.3. Global Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Breast Cancer Treatment
- Hormone Replacement Therapy (HRT)
- Infertility Treatment
- Post-Menopausal Osteoporosis
- Other Applications
7. Estrogen Blockers Market Regional And Country Analysis
- 7.1. Global Estrogen Blockers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Estrogen Blockers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Estrogen Blockers Market
- 8.1. Asia-Pacific Estrogen Blockers Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Estrogen Blockers Market
- 9.1. China Estrogen Blockers Market Overview
- 9.2. China Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Estrogen Blockers Market
- 10.1. India Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Estrogen Blockers Market
- 11.1. Japan Estrogen Blockers Market Overview
- 11.2. Japan Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Estrogen Blockers Market
- 12.1. Australia Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Estrogen Blockers Market
- 13.1. Indonesia Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Estrogen Blockers Market
- 14.1. South Korea Estrogen Blockers Market Overview
- 14.2. South Korea Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Estrogen Blockers Market
- 15.1. Western Europe Estrogen Blockers Market Overview
- 15.2. Western Europe Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Estrogen Blockers Market
- 16.1. UK Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Estrogen Blockers Market
- 17.1. Germany Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Estrogen Blockers Market
- 18.1. France Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Estrogen Blockers Market
- 19.1. Italy Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Estrogen Blockers Market
- 20.1. Spain Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Estrogen Blockers Market
- 21.1. Eastern Europe Estrogen Blockers Market Overview
- 21.2. Eastern Europe Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Estrogen Blockers Market
- 22.1. Russia Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Estrogen Blockers Market
- 23.1. North America Estrogen Blockers Market Overview
- 23.2. North America Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Estrogen Blockers Market
- 24.1. USA Estrogen Blockers Market Overview
- 24.2. USA Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Estrogen Blockers Market
- 25.1. Canada Estrogen Blockers Market Overview
- 25.2. Canada Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Estrogen Blockers Market
- 26.1. South America Estrogen Blockers Market Overview
- 26.2. South America Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Estrogen Blockers Market
- 27.1. Brazil Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Estrogen Blockers Market
- 28.1. Middle East Estrogen Blockers Market Overview
- 28.2. Middle East Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Estrogen Blockers Market
- 29.1. Africa Estrogen Blockers Market Overview
- 29.2. Africa Estrogen Blockers Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Estrogen Blockers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Estrogen Blockers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Estrogen Blockers Market Competitive Landscape And Company Profiles
- 30.1. Estrogen Blockers Market Competitive Landscape
- 30.2. Estrogen Blockers Market Company Profiles
- 30.2.1. Pfizer Inc
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche AG
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Merck & Co. Inc
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Novartis AG
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Sanofi S.A
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. Pfizer Inc
31. Estrogen Blockers Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC
- 31.2. GlaxoSmithKline plc
- 31.3. Eli Lilly and Company
- 31.4. Viatris Inc
- 31.5. Teva Pharmaceutical Industries Ltd.
- 31.6. Fresenius Kabi AG
- 31.7. Sun Pharmaceutical Industries Ltd.
- 31.8. Ipsen S.A.
- 31.9. Cadila Pharmaceuticals Ltd.
- 31.10. Intas Pharmaceuticals Limited
- 31.11. Dr. Reddy's Laboratories Ltd.
- 31.12. Hikma Pharmaceuticals PLC
- 31.13. Amneal Pharmaceuticals Inc.
- 31.14. Lupin Limited
- 31.15. Glenmark Pharmaceuticals Limited
32. Global Estrogen Blockers Market Competitive Benchmarking
33. Global Estrogen Blockers Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Estrogen Blockers Market
35. Estrogen Blockers Market Future Outlook and Potential Analysis
- 35.1 Estrogen Blockers Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Estrogen Blockers Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Estrogen Blockers Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
